Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Progressive Injury in Chronic Multiple Sclerosis Lesions Is Gender-Specific: A DTI Study.
[Subcutaneous immunoglobulin. Treatment in chronic inflammatory demyelinating polyradiculo-neuropathy].
Characteristics of flow through the internal jugular veins at cervical C2/C3 and C5/C6 levels for multiple sclerosis patients using MR phase contrast imaging.
Spatial modeling of multiple sclerosis for disease subtype prediction.
TIP30 inhibits oligodendrocyte precursor cell differentiation via cytoplasmic sequestration of Olig1.
Registers of multiple sclerosis in Denmark.
Multiple sclerosis: The elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13.
Inhibition of hydroxymethylglutaryl-coenzyme a reductase reduces Th1 development and promotes Th2 development.
Risk of suicide and suicide attempts associated with physical disorders: a population-based, balancing score-matched analysis.
Evaluation of Retinoids for Induction of the Redundant Gene ABCD2 as an Alternative Treatment Option in X-Linked Adrenoleukodystrophy.
Treatment of neuromyelitis optica: state-of-the-art and emerging therapies.
Cognitive Processing Speed is Related to Fall Frequency in Older Adults with Multiple Sclerosis.
Diagnosing neuromyelitis optica.
Exploring the Role of Nerve Growth Factorin Multiple Sclerosis: Implications in Myelin Repair.
Multiple Sclerosis in the Levant: A Regional Consensus Statement.
An MR Brain Images Classifier System via Particle Swarm Optimization and Kernel Support Vector Machine.
Selective dorsal rhizotomy for spasticity not associated with cerebral palsy: reconsideration of surgical inclusion criteria.
Pituitary apoplexy presented with optic neuritis.
Diffusion-weighted imaging and demyelinating diseases: new aspects of an old advanced sequence.
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis.
Schwann Cell Expressed Nogo-B Modulates Axonal Branching of Adult Sensory Neurons Through the Nogo-B Receptor NgBR.
Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro.
Multicontrast MRI Quantification of Focal Inflammation and Degeneration in Multiple Sclerosis.
HDAC1/2-Dependent P0 Expression Maintains Paranodal and Nodal Integrity Independently of Myelin Stability through Interactions with Neurofascins.
Pages
« first
‹ previous
…
468
469
470
471
472
473
474
475
476
…
next ›
last »